HOME >> BIOLOGY >> NEWS
Framingham heart study finds strong link between overweight/obesity & risk for heart failure

While extreme obesity has been associated with heart failure, until now, data have been limited regarding the influence of overweight and lesser degrees of obesity on the risk of this disease. According to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI), excess body weight is strongly and independently associated with an increased risk of heart failure. This risk, which increases continuously with increasing degrees of body weight, is 34 percent higher for overweight individuals and 104 percent higher for obese persons.

The large, community-based study investigated the relations between body mass index (BMI), a measure of excess weight for height, and the risk of heart failure in over 5,000 participants in the NHLBI's Framingham Heart Study, a landmark epidemiological study that began in 1948. Study findings will be published in the August 1, 2002 issue of The New England Journal of Medicine.

"Obesity has reached epidemic proportions in the United States and it is increasing," said NHLBI Director Dr. Claude Lenfant. "While the death rate from heart disease has decreased by 60 percent over the last 40 years, the death rate from heart failure has not declined. This study suggests that obesity is an important risk factor for heart failure in both women and men. Promoting optimal body weight may help reduce the burden of heart failure we're seeing," he added.

An estimated 61 percent of U.S. adults aged 20-74 years are either overweight or obese. About 34 percent of these people are overweight and 27 percent or 50 million people are obese. Nearly 5 million people in the U.S. have heart failure, a condition in which the heart cannot pump enough blood through the body.

"It was unclear from the scientific literature whether lesser degrees of obesity predispose an individual for heart failure, as most of the existing studies were limited to people who were severely obese (BMIs over 40)," said Dr. Satish
'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
31-Jul-2002


Page: 1 2 3

Related biology news :

1. Dietary Determinants Of Iron Stores In A Free-Living Elderly Population: The Framingham Heart Study
2. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
3. Screen siblings, parents of infants with severe heart abnormalities
4. Recent evolution at a single gene may have brought down heart disease risk in some human groups
5. How do you mend a broken heart?
6. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
7. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
8. Putting energy into heart protection
9. Rare mutations can significantly increase risk factor for heart disease
10. Smart gene therapy protects against damage from heart attack
11. University of Pittsburgh medical center among first to implant heart assist device

Post Your Comments:
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: